---
figid: PMC6592864__BPH-176-2433-g002
figtitle: Proposed mechanisms for mTOR signalling in the heart, mediated by A1‐ and
  B‐adrenoceptors
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC6592864
filename: BPH-176-2433-g002.jpg
figlink: pmc/articles/PMC6592864/figure/bph14616-fig-0002/
number: F2
caption: Proposed mechanisms for mTOR signalling in the heart, mediated by α1‐ and
  β‐adrenoceptors. Activation of α1‐adrenoceptors (α1‐AR) results in increased levels
  of cytosolic Ca2+ through a classical pathway involving Gαq/11, PLC, phosphatidylinositol
  bisphosphate (PIP2), and inositol trisphosphate (IP3). Release of intracellular
  Ca2+ activates CaMKK and AMPK pathways. α1‐Adrenoceptors also activate mTORC2 via
  unknown mechanisms. AMPK and mTORC2 both play significant roles in GLUT4 translocation
  to the plasma membrane, resulting in increased glucose uptake. α1‐Adrenoceptors
  promote mTORC1 activation via diacyl glycerol (DAG), PKCδ, and Erk1/2, leading to
  increased activation of S6rp and 4EBP1, which promote protein translation. β1‐ and
  β2‐adrenoceptors (β1‐ AR, β2‐AR) both couple to Gαs, whereas β2‐adrenoceptors switch
  coupling to Gαi/o in pathological states such as heart failure. Overstimulation
  of β1‐adrenoceptors increases Ca2+ mobilization and mTORC1 activation leading to
  increased protein synthesis and inhibition of autophagy, resulting in apoptosis,
  fibrosis, and hypertrophy. In the later stages of heart failure, GRK2 overexpression
  results in adrenoceptor phosphorylation and interaction with β‐arrestin, thereby
  promoting receptor internalization. Activation of the β2‐adrenoceptor–Gαi/opathway
  inhibits cAMP production and counteracts the pro‐apoptotic effects of excessive
  β1‐ adrenoceptor stimulation. The β2‐adrenoceptors stimulate glucose uptake through
  mTORC2‐Akt activation
papertitle: Adrenoceptor regulation of the mechanistic target of rapamycin in muscle
  and adipose tissue.
reftext: Ling Yeong Chia, et al. Br J Pharmacol. 2019 Jul;176(14):2433-2448.
year: '2019'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9638801
figid_alias: PMC6592864__F2
figtype: Figure
redirect_from: /figures/PMC6592864__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6592864__BPH-176-2433-g002.html
  '@type': Dataset
  description: Proposed mechanisms for mTOR signalling in the heart, mediated by α1‐
    and β‐adrenoceptors. Activation of α1‐adrenoceptors (α1‐AR) results in increased
    levels of cytosolic Ca2+ through a classical pathway involving Gαq/11, PLC, phosphatidylinositol
    bisphosphate (PIP2), and inositol trisphosphate (IP3). Release of intracellular
    Ca2+ activates CaMKK and AMPK pathways. α1‐Adrenoceptors also activate mTORC2
    via unknown mechanisms. AMPK and mTORC2 both play significant roles in GLUT4 translocation
    to the plasma membrane, resulting in increased glucose uptake. α1‐Adrenoceptors
    promote mTORC1 activation via diacyl glycerol (DAG), PKCδ, and Erk1/2, leading
    to increased activation of S6rp and 4EBP1, which promote protein translation.
    β1‐ and β2‐adrenoceptors (β1‐ AR, β2‐AR) both couple to Gαs, whereas β2‐adrenoceptors
    switch coupling to Gαi/o in pathological states such as heart failure. Overstimulation
    of β1‐adrenoceptors increases Ca2+ mobilization and mTORC1 activation leading
    to increased protein synthesis and inhibition of autophagy, resulting in apoptosis,
    fibrosis, and hypertrophy. In the later stages of heart failure, GRK2 overexpression
    results in adrenoceptor phosphorylation and interaction with β‐arrestin, thereby
    promoting receptor internalization. Activation of the β2‐adrenoceptor–Gαi/opathway
    inhibits cAMP production and counteracts the pro‐apoptotic effects of excessive
    β1‐ adrenoceptor stimulation. The β2‐adrenoceptors stimulate glucose uptake through
    mTORC2‐Akt activation
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - tws
  - ac
  - tRNA:Glu-CTC-1-1
  - tRNA:Glu-CTC-3-9
  - tRNA:Glu-CTC-2-2
  - tRNA:Glu-CTC-3-6
  - tRNA:Glu-CTC-3-3
  - tRNA:Glu-CTC-3-8
  - tRNA:Glu-CTC-3-4
  - tRNA:Glu-CTC-3-5
  - tRNA:Glu-CTC-3-2
  - tRNA:Glu-CTC-2-3
  - tRNA:Glu-CTC-3-1
  - tRNA:Glu-CTC-2-1
  - tRNA:Glu-CTC-3-7
  - norpA
  - sl
  - Plc21C
  - Pka-C1
  - Pka-R2
  - Pka-C3
  - Pka-R1
  - Pka-C2
  - Crtc
  - sr
  - inaC
  - Pkc98E
  - aPKC
  - Pkc53E
  - SNF4Agamma
  - AMPKalpha
  - Thor
  - Atg1
  - Akt
  - Erk7
  - rl
  - SLC2A4
  - ADCY1
  - ADCY2
  - ADCY3
  - ADCY4
  - ADCY5
  - ADCY6
  - ADCY7
  - ADCY8
  - ADCY9
  - ADCY10
  - HSPG2
  - PLCE1
  - PLCZ1
  - PLCB1
  - PLCB2
  - PLCB3
  - PLCB4
  - PLCD1
  - PLCD3
  - PLCD4
  - PLCG1
  - PLCG2
  - PRKAR1A
  - PRKAR1B
  - PRKAR2A
  - PRKAR2B
  - PRKACA
  - PRKACB
  - PRKACG
  - MTOR
  - RPTOR
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - EIF4EBP1
  - ULK1
  - AKT1
  - AKT2
  - AKT3
  - MAPKAP1
  - RICTOR
  - MLST8
  - EPHB2
  - MAPK1
  - MAPK3
  - Glucose
  - Fibrosis
---
